RMD vs STKL · P/E 29, rev $5.65B vs P/E 50, rev $723.7M
ResMed Inc (RMD) versus SunOpta Inc. (STKL) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
SunOpta Inc. (STKL) is a beverages - non-alcoholic company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported STKL revenue for 2024-12-28 was $723.7M. Net income was -$17.4M. STKL currently screens at market cap $771.0M and trailing P/E 50.0.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. STKL currently screens at market cap $771.0M and trailing P/E 50.0.
Not investment advice. Open the RMD and STKL stock pages for the full models.
Not investment advice.